[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sigma Pharmaceuticals Ltd (SIG) - Financial and Strategic SWOT Analysis Review

July 2017 | 35 pages | ID: S6462684C11EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sigma Pharmaceuticals Ltd (SIG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sigma Pharmaceuticals Ltd (Sigma) is a wholesale and distribution company that carries out wholesale, retail, supply and distribution of prescription and over the counter products to pharmacy outlets. It is one of the largest pharmacy-led networks in Australia with branded and independent pharmacies in its network. Its major retail brands include Amcal, Amcal Max, Guardian, Pharmasave, Chemist King and Discount Drug Stores. It offers OTC medicines, prescription drugs and general retail merchandise to retail pharmacies. The company offers products through its subsidiaries in New Zealand and Australia. Sigma is headquartered in Rowville, Victoria, Australia.

Sigma Pharmaceuticals Ltd Key Recent Developments

Mar 30,2016: Sigma Pharmaceuticals Announces Board appointment
Mar 23,2016: Sigma profits down despite higher sales

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Sigma Pharmaceuticals Ltd - Key Facts
Sigma Pharmaceuticals Ltd - Key Employees
Sigma Pharmaceuticals Ltd - Key Employee Biographies
Sigma Pharmaceuticals Ltd - Major Products and Services
Sigma Pharmaceuticals Ltd - History
Sigma Pharmaceuticals Ltd - Company Statement
Sigma Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Sigma Pharmaceuticals Ltd - Business Description
Sigma Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Sigma Pharmaceuticals Ltd - Strengths
Sigma Pharmaceuticals Ltd - Weaknesses
Sigma Pharmaceuticals Ltd - Opportunities
Sigma Pharmaceuticals Ltd - Threats
Sigma Pharmaceuticals Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sigma Pharmaceuticals Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 30, 2016: Sigma Pharmaceuticals Announces Board appointment

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sigma Pharmaceuticals Ltd, Key Facts
Sigma Pharmaceuticals Ltd, Key Employees
Sigma Pharmaceuticals Ltd, Key Employee Biographies
Sigma Pharmaceuticals Ltd, Major Products and Services
Sigma Pharmaceuticals Ltd, History
Sigma Pharmaceuticals Ltd, Subsidiaries
Sigma Pharmaceuticals Ltd, Key Competitors
Sigma Pharmaceuticals Ltd, Ratios based on current share price
Sigma Pharmaceuticals Ltd, Annual Ratios
Sigma Pharmaceuticals Ltd, Annual Ratios (Cont.1)
Sigma Pharmaceuticals Ltd, Annual Ratios (Cont.2)
Sigma Pharmaceuticals Ltd, Interim Ratios
Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sigma Pharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Sigma Pharmaceuticals Ltd, Performance Chart (2013 - 2017)
Sigma Pharmaceuticals Ltd, Ratio Charts
Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sigma Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

ALS Limited
Australian Pharmaceutical Industries Ltd
Discount Drug Stores Pty Ltd
Starpharma Holdings Ltd
Vita Life Sciences Ltd


More Publications